Related Experiment Video
Updated: Jun 2, 2026
06:31
Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
Published on: May 20, 2015
Alpha-fetoprotein-producing primary lung carcinoma: a case report
Masahiro Kitada1, Keisuke Ozawa, Kazuhiro Sato
1Department of Surgery, Asahikawa Medical University, Japan. k1111@asahikawa-med.ac.jp
World Journal of Surgical Oncology
|May 11, 2011
Summary
This case study highlights a rare Alpha-fetoprotein (AFP)-producing lung adenocarcinoma. Surgical resection led to a decrease in AFP levels and no signs of recurrence, suggesting effective treatment for this specific lung cancer subtype.
Area of Science:
- Oncology
- Pulmonology
- Biomarkers
Background:
- Alpha-fetoprotein (AFP)-producing lung adenocarcinoma is a rare subtype of lung cancer.
- Its distinct characteristics and clinical presentation require further elucidation.
Observation:
- A 69-year-old male presented with epigastric pain, later found to have a 70 mm right lower lung mass with hilar lymph node metastasis.
- Elevated serum AFP (4620 ng/ml) was a key finding, alongside mild elevations in CEA and CA19-9.
- Transbronchial biopsy confirmed lung cancer, and immunostaining revealed AFP-positive tumor cells.
Findings:
- The patient underwent successful right lower lobectomy and mediastinal lymph node dissection.
- Post-surgery, serum AFP levels normalized within two weeks.
- No tumor recurrence has been observed to date.
Implications:
- This case underscores the importance of considering AFP as a tumor marker in specific lung adenocarcinoma presentations.
- Surgical intervention appears to be an effective treatment for localized AFP-producing lung adenocarcinoma.
- Further research into AFP-producing lung cancers can improve diagnostic and therapeutic strategies.
